MeSH D007246 - infertility
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000091662:Genital diseases
0 Companies
0 Drugs
Success rate
D007246:Â
Infertility
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Leuprolide acetate | Viadur |  | 2000-03-03 |  |  |
| Sandoz | Leuprolide acetate | Leuprolide |  | 1998-08-04 |  |  |
| Organon | Follitropin beta | Follistim |  | 1997-09-29 | $260 M | Q2/24-Q1/25 |
| Follitropin beta | Puregon |  | 1996-05-02 |  |  | |
| AbbVie | Norethindrone, Leuprolide acetate | Lupaneta Pack |  | 2012-12-14 |  |  |
| Leuprolide acetate | Lupron |  | 1985-04-09 |  |  | |
| Leuprolide acetate | Lupron Depot |  | 1989-01-26 |  |  | |
| Leuprolide acetate | Lupron Depot-ped | 2028-03-22 | 1993-04-16 |  |  | |
| Sanofi | Leuprolide acetate | Leuprolide |  | 2001-11-29 |  |  |
| Merck & Co | Follitropin beta | Fertavid |  | 2009-03-19 |  |  |
| Follitropin alfa | Gonal-f |  | 1995-10-20 |  |  | |
| Lutropin alfa, Follitropin alfa | Pergoveris |  | 2007-06-25 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
75%24/32
Phase 2
80%49/61
Phase 3
77%51/66
Approved: 5Overall Success rate: 47%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use